This review aims to evaluate the role of ITLN1 in cancer without imposing any inclusion criteria, to examine pro- and anticancer roles for ITLN1 and to discuss whether the relationship between ITLN and cancer is mediated by obesity. This evidence concerns the gene ITLN1 and obesity due to melanocortin 4 receptor deficiency.